EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieKohortenstudieOpen Access · CC BY 4.0

Catheter-directed versus standard therapy in intermediate–high-risk pulmonary embolism: A retrospective cohort study

Louis Pot, Etienne Cassiani-Ingoni, Marc Gainnier, Julien Carvelli, Mohamed Boucekine, Pauline Moyse, Florent Arregle, Octave Cannac, Damien Barrau, Marc Laine, Jennifer Cautela, David Montani und 1 weitere

Archives of Cardiovascular Diseases · 2026-04 · 119 (4) · 263-272

DOI: 10.1016/j.acvd.2025.08.014 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Archives of Cardiovascular Diseases, 2026-04. Verfasst von Louis Pot und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, Réanimation des Urgences, Hôpital de La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), 13385 Marse…. Hauptthemen laut MEDLINE: Pulmonary Embolism, Anticoagulants, Thrombolytic Therapy, Fibrinolytic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Interventional techniques for managing acute-phase pulmonary embolism (PE) are under investigation, but their efficacy compared with anticoagulant alone remains uncertain. AIM: To assess the efficacy and safety of catheter-directed interventions (CDI) compared with standard anticoagulation management in patients with intermediate-high-risk pulmonary embolism. METHODS: We conducted a large-scale, retrospective, multicentre cohort study of patients hospitalized with intermediate-high-risk PE between 2017 and 2024 in three intensive care units (ICU) and two cardiac ICUs. Patients were stratified based on the use of CDI versus standard anticoagulation. Data on demographics, clinical characteristics and outcomes were collected and analysed. RESULTS: Among 1637 patients admitted for PE, 549 met the inclusion criteria. Of these, 258 patients (47%) received CDI, including 213 (83%) undergoing catheter-directed thrombolysis and 45 (17%) underwent thromboaspiration. The primary composite outcome of in-hospital mortality or systemic thrombolysis was significantly lower in the CDI group versus the standard-treatment group (3.1% vs. 7.2%; P=0.031); multivariable analysis demonstrated a 65% risk reduction (adjusted odds ratio 0.35, 95% confidence interval 0.14-0.80). Minor bleeding events were more frequent with CDI whereas major bleeding complications were similar between groups. Echocardiographic evaluations showed no significant differences in the incidence of pulmonary hypertension, but demonstrated a significant reduction in early and late systolic pulmonary artery pressure in the CDI group. CONCLUSION: CDI appears to provide potential benefits in the management of intermediate-high-risk PE, including a reduction in the composite outcome of in-hospital mortality or systemic thrombolysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismAnticoagulantsThrombolytic TherapyFibrinolytic AgentsThrombectomyHumansRetrospective StudiesFemaleMaleMiddle AgedAgedRisk FactorsTreatment OutcomeRisk AssessmentHospital MortalityTime FactorsHemorrhageAged, 80 and over

Stichwörter der Autor:innen

Catheter-directed interventionChronic thromboembolic pulmonary hypertensionIn-hospital mortalityPulmonary embolismSystemic thrombolysis

Substanzen

AnticoagulantsFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Intensive Care Medicine, Réanimation des Urgences, Hôpital de La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), 13385 Marseille, France. Electronic address: louis.pot@ap-hm.fr.
  • Department of Intensive Care Medicine, Réanimation des Urgences, Hôpital de La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), 13385 Marseille, France.
  • Center for Studies and Research on Health Services and Quality of Life, Aix-Marseille Université, 13385 Marseille, France.
  • Department of Cardiology, Soins intensifs de Cardiologie, Hôpital de La Timone, Assistance Publique-Hôpitaux de Marseille (AP-HM), 13385 Marseille, France.
  • Department of Intensive Care Medicine, Médecine Intensive-Réanimation, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille (AP-HM), 13915 Marseille, France.
  • Department of Cardiology, Soins Intensifs de Cardiologie, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille (AP-HM), 13915 Marseille, France.

Zitieren

APA

Pot, L., Cassiani-Ingoni, E., Gainnier, M., Carvelli, J., Boucekine, M., Moyse, P., Arregle, F., Cannac, O., Barrau, D., Laine, M., Cautela, J., Montani, D., & Bonello, L. (2026). Catheter-directed versus standard therapy in intermediate–high-risk pulmonary embolism: A retrospective cohort study. Archives of Cardiovascular Diseases, 119(4), 263-272. https://doi.org/10.1016/j.acvd.2025.08.014

Vancouver

Pot L, Cassiani-Ingoni E, Gainnier M, Carvelli J, Boucekine M, Moyse P, et al. Catheter-directed versus standard therapy in intermediate–high-risk pulmonary embolism: A retrospective cohort study. Archives of Cardiovascular Diseases. 2026;119(4):263-272. doi:10.1016/j.acvd.2025.08.014

BibTeX
@article{Pot2026,
  author = {Pot, Louis and Cassiani-Ingoni, Etienne and Gainnier, Marc and Carvelli, Julien and Boucekine, Mohamed and Moyse, Pauline and Arregle, Florent and Cannac, Octave and Barrau, Damien and Laine, Marc and Cautela, Jennifer and Montani, David and Bonello, Laurent},
  title = {Catheter-directed versus standard therapy in intermediate–high-risk pulmonary embolism: A retrospective cohort study},
  journal = {Archives of Cardiovascular Diseases},
  year = {2026},
  volume = {119},
  number = {4},
  pages = {263--272},
  doi = {10.1016/j.acvd.2025.08.014}
}
Kostenlos starten →